Promotional price valid on web orders only. Your contract pricing may differ. Interested in signing up for a dedicated account number?
Learn More
  1. Home
  2. Products
  3. 5000284944

Medchemexpress LLC Benzamide, 4-butoxy-N-[1,4-dihydro-2-(4-hydroxyphenyl)-4-oxo-3(2H)-quinazolinyl]- | 871100-12-8 | 99.8% | 431.48 Da | C25H25N3O4 | 25 MG
SDP

Catalog No. 5000284944
Encompass_Preferred

Quin-C7 is an orally active antagonist of the formyl peptide receptor 2 (FPR2/ALX) with reported anti-inflammatory activity in DSS-induced colitis models. Supplied as a high-purity research reagent, it is provided in solid form and as a DMSO solution for preclinical studies.

  • Orally active FPR2/ALX antagonist
  • Demonstrated anti-inflammatory effect in DSS-induced colitis models
  • High purity suitable for preclinical research
  • Supplied as powder and 10 mM solution in DMSO
  • Accompanied by datasheet and certificate of analysis

Catalog No. 50-002-84944 Supplier Medchemexpress LLC Supplier No. HYW66877525MG
May include imposed supplier surcharges.
Add to Cart
Add to Cart

missing translation for 'validMainframeMsg'

Quin-C7 is an orally active antagonist of the formyl peptide receptor 2 (FPR2/ALX) with reported anti-inflammatory activity in DSS-induced colitis models. Supplied as a high-purity research reagent, it is provided in solid form and as a DMSO solution for preclinical studies.

  • Orally active FPR2/ALX antagonist
  • Demonstrated anti-inflammatory effect in DSS-induced colitis models
  • High purity suitable for preclinical research
  • Supplied as powder and 10 mM solution in DMSO
  • Accompanied by datasheet and certificate of analysis

Product Title
Select an issue

By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.